We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHOC icon
9976
Strive US Semiconductor ETF
SHOC
$227M
-126
Closed -$5.63K
SHPH icon
9977
Shuttle Pharmaceuticals
SHPH
$1.81M
-1
Closed -$455
SID icon
9978
Companhia Siderúrgica Nacional
SID
$1.34B
-2,642
Closed -$8.27K
SILO icon
9979
Silo Pharma
SILO
$4.8M
-25
Closed -$729
SIXH icon
9980
ETC 6 Meridian Hedged Equity Index Option ETF
SIXH
$572M
-2,177
Closed -$77.4K
SLGL icon
9981
Sol-Gel Technologies
SLGL
$278M
-341
Closed -$3.34K
SLNG icon
9982
Stabilis Solutions
SLNG
$88.7M
-502
Closed -$2.11K
SLRN
9983
CALL
DELISTED
ACELYRIN
SLRN
-25,600
Closed -$173K
SMI
9984
DELISTED
VanEck HIP Sustainable Muni ETF
SMI
-29
Closed -$1.34K
SMIZ icon
9985
Zacks Small/Mid Cap ETF
SMIZ
$271M
-31
Closed -$981
SMOT icon
9986
VanEck Morningstar SMID Moat ETF
SMOT
$336M
-1,140
Closed -$38.9K
SNOV icon
9987
FT Vest US Small Cap Moderate Buffer ETF November
SNOV
$115M
-313
Closed -$6.81K
SNTI icon
9988
Senti Biosciences Holdings
SNTI
$11.2M
-73
Closed -$276
FTH
9989
Faeth Therapeutics
FTH
$743M
-7
Closed -$146
SOBR icon
9990
SOBR Safe
SOBR
$1.61M
-1
Closed -$455
SOND
9991
DELISTED
Sonder
SOND
-296
Closed -$876
SONM icon
9992
DNA X Inc
SONM
$4.84M
-28
Closed -$3.04K
SOTK icon
9993
Sono-Tek
SOTK
$80.6M
-54
Closed -$264
SOVF icon
9994
Sovereign's Capital Flourish Fund
SOVF
$96.9M
-552
Closed -$16.4K
SOXX icon
9995
PUT
iShares Semiconductor ETF
SOXX
$41.7B
-1,200
Closed -$271K
SOYB icon
9996
Teucrium Soybean Fund
SOYB
$61.1M
-2,687
Closed -$67.7K
CUSD
9997
DELISTED
CrossingBridge Ultra-Short Duration ETF
CUSD
-15
Closed -$321
SPMO icon
9998
Invesco S&P 500 Momentum ETF
SPMO
$20.7B
-2,260
Closed -$181K
SPPP
9999
Sprott Physical Platinum and Palladium Trust
SPPP
$587M
-9,291
Closed -$89.7K
SPRE icon
10000
SP Funds S&P Global REIT Sharia ETF
SPRE
$223M
-155
Closed -$3.14K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.